DK1500390T3 - Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1500390T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; dosage form; solid dosage; preparation; desmopressin
Prior art date: 2003-07-25

Application number

DK03016945T

Other languages

English (en)

Inventor

Hakan Lomryd

Helena Nicklasson

Lars-Erik Olsson

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-25

Filing date

2003-07-25

Publication date

2005-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1500390(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-07-25 Application filed by Ferring Bv filed Critical Ferring Bv

2005-09-19 Application granted granted Critical

2005-09-19 Publication of DK1500390T3 publication Critical patent/DK1500390T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK03016945T 2003-07-25 2003-07-25 Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf DK1500390T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03016945A EP1500390B1 (en)	2003-07-25	2003-07-25	Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof
US10/626,857 US7022340B2 (en)	2003-07-25	2003-07-25	Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Publications (1)

Publication Number	Publication Date
DK1500390T3 true DK1500390T3 (da)	2005-09-19

Family

ID=34117527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03016945T DK1500390T3 (da)	2003-07-25	2003-07-25	Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf

Country Status (21)

Country	Link
US (1)	US7022340B2 (da)
EP (1)	EP1500390B1 (da)
JP (1)	JP4430673B2 (da)
KR (1)	KR20050104331A (da)
AT (1)	ATE301990T1 (da)
AU (1)	AU2004260625B2 (da)
BR (1)	BRPI0412905A (da)
CA (1)	CA2490335C (da)
DE (1)	DE60301351T2 (da)
DK (1)	DK1500390T3 (da)
ES (1)	ES2243840T3 (da)
IL (1)	IL187591A0 (da)
MX (1)	MXPA06000903A (da)
NO (1)	NO327328B1 (da)
NZ (1)	NZ544104A (da)
PL (1)	PL379704A1 (da)
PT (1)	PT1500390E (da)
RU (1)	RU2303439C2 (da)
SI (1)	SI1500390T1 (da)
TW (1)	TWI268782B (da)
WO (1)	WO2005011640A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0210397D0 (en) *	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
US7094545B2 (en) *	2003-04-30	2006-08-22	Ferring Bv	Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) *	2003-07-25	2010-06-09	凡林有限公司	固体剂型药物组合物及其制造方法
PT1530967E (pt) *	2003-11-13	2006-09-29	Ferring Bv	Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
CA2490601C (en) *	2003-12-29	2006-05-02	Ferring B.V.	Method for preparing solid dosage form of desmopressin
US7018653B2 (en) *	2003-12-29	2006-03-28	Ferring B.V.	Method for preparing solid dosage form of desmopressin
SE0600482L (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2472539C2 (ru)	2007-08-06	2013-01-20	Аллерган, Инк.	Способы и устройства для доставки препарата десмопрессина
ES2319054B1 (es)	2007-08-06	2010-02-12	Gp Pharm S.A.	Composicion farmaceutica oral de desmopresina.
US20090232896A1 (en) *	2008-03-11	2009-09-17	Mallinckrodt Inc.	Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
ES2710454T3 (es) *	2008-05-21	2019-04-25	Ferring Bv	Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
WO2010038698A1 (ja) *	2008-09-30	2010-04-08	三井化学株式会社	繊維強化樹脂組成物およびその成形体
JP2022130075A (ja) *	2021-02-25	2022-09-06	フロイント産業株式会社	顆粒及びその製造方法、並びに錠剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8306367L (sv) *	1983-11-18	1985-05-19	Ferring Ab	Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) *	1985-08-02	1987-06-23	Stauffer Chemical Company	Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) *	1986-03-24	1989-04-11	Em Diagnostic Systems, Inc.	Method of preparing particles suitable for tabletting into diagnostic reagents
IE77165B1 (en) *	1991-01-30	1997-12-03	Wellcome Found	Water-dispersible tablet containing acyclovir
US5482931A (en)	1993-06-29	1996-01-09	Ferring Ab	Stabilized pharmaceutical peptide compositions
AU1677095A (en)	1994-01-11	1995-08-01	Alkermes Controlled Therapeutics, Inc.	Oral dosage form of desmopressin (ddavp)
SE9400918L (sv) *	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
US5849322A (en)	1995-10-23	1998-12-15	Theratech, Inc.	Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en)	1995-12-23	1996-02-28	Knoll Ag	Therapeutic agents
DE19602757A1 (de) *	1996-01-26	1997-07-31	Boehringer Mannheim Gmbh	Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
SE9604341D0 (sv) *	1996-11-26	1996-11-26	Ferring Bv	Hepta-peptide oxytocin analogue
WO2000009423A1 (es)	1998-08-11	2000-02-24	Jaime Marti Sala	Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de)	2000-02-16	2002-05-27	Gebro Pharma Gmbh	Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
PE20011227A1 (es)	2000-04-17	2002-01-07	Chiesi Farma Spa	Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
WO2001078696A2 (en)	2000-04-17	2001-10-25	Vectura Limited	Formulations for use in inhaler devices
GB0009469D0 (en) *	2000-04-17	2000-06-07	Vectura Ltd	Improvements in or relating to formalities for use in inhaler devices
GB0010709D0 (en)	2000-05-03	2000-06-28	Vectura Ltd	Powders for use a in dry powder inhaler
CN100551358C (zh)	2000-06-27	2009-10-21	维克多瑞有限公司	用于药物组合物的颗粒的制备方法
JP3626483B2 (ja) *	2001-05-10	2005-03-09	山之内製薬株式会社	口腔内速崩壊性錠剤およびその製造法
HUP0401732A2 (hu)	2001-10-15	2004-12-28	Röhm GmbH & Co. KG	Kopolimerek használata aktív szerként peptidet és fehérjét tartalmazó galenikus formák előállításához
WO2003094886A2 (en)	2002-05-07	2003-11-20	Ferring Bv	Desmopressin in an orodispersible dosage form
ATE291419T1 (de) *	2003-04-30	2005-04-15	Ferring Bv	Feste dosierungsform mit desmopressin
US7094545B2 (en) *	2003-04-30	2006-08-22	Ferring Bv	Pharmaceutical composition as solid dosage form and method for manufacturing thereof

2003
- 2003-07-25 DK DK03016945T patent/DK1500390T3/da active
- 2003-07-25 ES ES03016945T patent/ES2243840T3/es not_active Expired - Lifetime
- 2003-07-25 DE DE60301351T patent/DE60301351T2/de not_active Expired - Lifetime
- 2003-07-25 EP EP03016945A patent/EP1500390B1/en not_active Revoked
- 2003-07-25 US US10/626,857 patent/US7022340B2/en not_active Expired - Fee Related
- 2003-07-25 SI SI200330100T patent/SI1500390T1/sl unknown
- 2003-07-25 PT PT03016945T patent/PT1500390E/pt unknown
- 2003-07-25 AT AT03016945T patent/ATE301990T1/de active
2004
- 2004-07-19 MX MXPA06000903A patent/MXPA06000903A/es active IP Right Grant
- 2004-07-19 CA CA002490335A patent/CA2490335C/en not_active Expired - Fee Related
- 2004-07-19 RU RU2005141230/15A patent/RU2303439C2/ru not_active IP Right Cessation
- 2004-07-19 JP JP2006520833A patent/JP4430673B2/ja not_active Expired - Fee Related
- 2004-07-19 NZ NZ544104A patent/NZ544104A/en not_active IP Right Cessation
- 2004-07-19 BR BRPI0412905-9A patent/BRPI0412905A/pt not_active Application Discontinuation
- 2004-07-19 PL PL379704A patent/PL379704A1/pl not_active Application Discontinuation
- 2004-07-19 KR KR1020057006309A patent/KR20050104331A/ko not_active Ceased
- 2004-07-19 AU AU2004260625A patent/AU2004260625B2/en not_active Ceased
- 2004-07-19 WO PCT/EP2004/051538 patent/WO2005011640A2/en not_active Ceased
- 2004-07-23 TW TW093122090A patent/TWI268782B/zh not_active IP Right Cessation
2005
- 2005-04-19 NO NO20051896A patent/NO327328B1/no not_active IP Right Cessation
2007
- 2007-11-22 IL IL187591A patent/IL187591A0/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
TW200509995A (en)	2005-03-16
KR20050104331A (ko)	2005-11-02
PL379704A1 (pl)	2006-11-13
RU2303439C2 (ru)	2007-07-27
AU2004260625B2 (en)	2007-12-06
DE60301351T2 (de)	2006-01-19
EP1500390B1 (en)	2005-08-17
IL187591A0 (en)	2008-03-20
SI1500390T1 (sl)	2006-02-28
US20050019392A1 (en)	2005-01-27
BRPI0412905A (pt)	2006-09-26
ATE301990T1 (de)	2005-09-15
TWI268782B (en)	2006-12-21
NO327328B1 (no)	2009-06-08
WO2005011640A3 (en)	2005-03-24
DE60301351D1 (de)	2005-09-22
CA2490335A1 (en)	2005-01-25
NO20051896L (no)	2005-04-19
JP4430673B2 (ja)	2010-03-10
RU2005141230A (ru)	2006-07-10
MXPA06000903A (es)	2006-05-04
EP1500390A1 (en)	2005-01-26
WO2005011640A2 (en)	2005-02-10
HK1072009A1 (en)	2005-08-12
PT1500390E (pt)	2005-10-31
AU2004260625A1 (en)	2005-02-10
US7022340B2 (en)	2006-04-04
CA2490335C (en)	2006-01-31
JP2007517762A (ja)	2007-07-05
ES2243840T3 (es)	2005-12-01
NZ544104A (en)	2008-06-30

Publication	Publication Date	Title
IL187591A0 (en)	2008-03-20	Pharmaceutical composition as solid dosage from and method for manufacturing thereof
MY148680A (en)	2013-05-31	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
SG146608A1 (en)	2008-10-30	Rapid dissolution formulation of a calcium receptor-active compound
MY148773A (en)	2013-05-31	Galenic formulations of organic compounds
WO2003082853A8 (en)	2004-05-06	New compounds
EA200700566A1 (ru)	2008-08-29	Фармацевтические композиции, включающие леветирацетам, и способы их получения
EA200401583A1 (ru)	2005-06-30	Таблетка лазофоксифена и ее покрытие
MY138734A (en)	2009-07-31	Casr antagonist
EA200301040A1 (ru)	2004-04-29	Способ производства фармацевтической композиции низкой дозы
ATE329581T1 (de)	2006-07-15	Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
SE0102440D0 (sv)	2001-07-05	New compound
AR046226A1 (es)	2005-11-30	Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
TW200606164A (en)	2006-02-16	New compounds
GB0212410D0 (en)	2002-07-10	Organic compounds
TW200800984A (en)	2008-01-01	New compounds
TW200640465A (en)	2006-12-01	New pharmaceutically active compounds for the treatment of respiratory diseases
DE60302951D1 (de)	2006-02-02	Pyroglutaminsäure-salz von Amlodipin
DE60300414D1 (de)	2005-04-28	Feste Dosierungsform mit Desmopressin
IL163025A (en)	2010-06-16	Prucalopride - n - oxides, their preparation and pharmaceutical compositions comprising them
EA200401082A1 (ru)	2005-04-28	Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
AR046261A1 (es)	2005-11-30	Composicion farmaceutica como forma de dosificacion solida y metodo para su fabricacion
TW200518749A (en)	2005-06-16	Stabilised pharmaceutical compositions